Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1300

1.

Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma.

Nazzani S, Preisser F, Mazzone E, Marchioni M, Bandini M, Tian Z, Mistretta FA, Shariat SF, Soulières D, Saad F, Montanari E, Luzzago S, Briganti A, Carmignani L, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Mar 29. pii: S1558-7673(19)30083-7. doi: 10.1016/j.clgc.2019.03.003. [Epub ahead of print]

PMID:
31005472
2.

Impact of tumor size on cancer specific mortality after local tumor ablation in T1a renal cell carcinoma.

Palumbo C, Cyr SJ, Mazzone E, Mistretta FA, Knipper S, Pecoraro A, Tian Z, Shariat SF, Saad F, Simeone C, Briganti A, Kapoor A, Antonelli A, Karakiewicz PI.

J Endourol. 2019 Apr 16. doi: 10.1089/end.2019.0179. [Epub ahead of print]

PMID:
30990074
3.

Importance of early treatment in metastatic prostate cancer: a question of life or death.

Saad F.

Lancet Oncol. 2019 Apr 12. pii: S1470-2045(19)30155-X. doi: 10.1016/S1470-2045(19)30155-X. [Epub ahead of print] No abstract available.

PMID:
30987940
4.

Proteases and their inhibitors as prognostic factors for high-grade serous ovarian cancer.

Trudel D, Avarvarei LM, Orain M, Turcotte S, Plante M, Grégoire J, Kappelhoff R, Labbé DP, Bachvarov D, Têtu B, Overall CM, Bairati I.

Pathol Res Pract. 2019 Mar 2. pii: S0344-0338(18)31674-1. doi: 10.1016/j.prp.2019.02.019. [Epub ahead of print]

PMID:
30987833
5.

Commentary: Prehabilitation for increasing ventilatory efficiency before lung resection: Amazing concept, but we're not there yet!

Ben Ali W, Liberman M, Perrault LP.

J Thorac Cardiovasc Surg. 2019 Mar 13. pii: S0022-5223(19)30562-8. doi: 10.1016/j.jtcvs.2019.02.094. [Epub ahead of print] No abstract available.

PMID:
30954302
6.

Single-balloon enteroscopic retrograde cholangiopancreatography in the setting of altered upper gastrointestinal anatomy.

Smith S, Stagg J, Naumann C.

Proc (Bayl Univ Med Cent). 2018 Oct 26;31(4):467-469. doi: 10.1080/08998280.2018.1499315. eCollection 2018 Oct.

7.

Contemporary North-American Assessment of Robot-assisted Surgery Rates and Total Hospital Charges for Major Surgical Uro-oncological Procedures.

Mazzone E, Mistretta FA, Knipper S, Tian Z, Larcher A, Widmer H, Zorn KC, Capitanio U, Graefen M, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

J Endourol. 2019 Mar 30. doi: 10.1089/end.2018.0840. [Epub ahead of print]

PMID:
30931607
8.

T cell Bispecific Antibodies in Node-Positive Breast Cancer: Novel Therapeutic Avenue for MHC class I Loss Variants.

Messaoudene M, Mourikis TP, Michels J, Fu Y, Bonvalet M, Lacroix-Trikki M, Routy B, Fluckiger A, Rusakiewicz S, Roberti MP, Cotteret S, Flament C, Poirier-Colame V, Jacquelot N, Ghiringhelli F, Caignard A, Eggermont AMM, Kroemer G, Marabelle A, Arnedos M, Vicier C, Dogan S, Jaulin F, Sammut SJ, Cope W, Caldas C, Delaloge S, McGranahan N, André F, Zitvogel L.

Ann Oncol. 2019 Mar 29. pii: mdz112. doi: 10.1093/annonc/mdz112. [Epub ahead of print]

PMID:
30924846
9.

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma.

Le Page C, Köbel M, Meunier L, Provencher DM, Mes-Masson AM, Rahimi K.

J Pathol Clin Res. 2019 Mar 28. doi: 10.1002/cjp2.131. [Epub ahead of print]

10.

Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification.

Monette A, Bergeron D, Ben Amor A, Meunier L, Caron C, Mes-Masson AM, Kchir N, Hamzaoui K, Jurisica I, Lapointe R.

J Immunother Cancer. 2019 Mar 28;7(1):86. doi: 10.1186/s40425-019-0544-x.

11.

Emerging therapeutic targets for patients with advanced prostate cancer.

Saad F, Shore N, Zhang T, Sharma S, Cho HK, Jacobs IA.

Cancer Treat Rev. 2019 Mar 19;76:1-9. doi: 10.1016/j.ctrv.2019.03.002. [Epub ahead of print] Review.

PMID:
30913454
12.

Failed immune responses across multiple pathologies share pan-tumor and circulating lymphocytic targets.

Monette A, Morou A, Al-Banna NA, Rousseau L, Lattouf JB, Rahmati S, Tokar T, Routy JP, Cailhier JF, Kaufmann DE, Jurisica I, Lapointe R.

J Clin Invest. 2019 Mar 26;130. pii: 125301. doi: 10.1172/JCI125301.

13.

Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors.

Elkrief A, El Raichani L, Richard C, Messaoudene M, Belkaid W, Malo J, Belanger K, Miller W, Jamal R, Letarte N, Wong P, Routy B.

Oncoimmunology. 2019 Feb 18;8(4):e1568812. doi: 10.1080/2162402X.2019.1568812. eCollection 2019.

PMID:
30906663
14.

Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer.

Rozenholc A, Samouelian V, Warkus T, Gauthier P, Provencher D, Sauthier P, Gauthier F, Drakopoulos P, Cormier B.

Gynecol Oncol. 2019 Mar 19. pii: S0090-8258(19)30296-3. doi: 10.1016/j.ygyno.2019.03.103. [Epub ahead of print]

PMID:
30902369
15.

Selection and Receipt of Kidney Replacement in Critically Ill Older Patients with AKI.

Bagshaw SM, Adhikari NKJ, Burns KEA, Friedrich JO, Bouchard J, Lamontagne F, McIntrye LA, Cailhier JF, Dodek P, Stelfox HT, Herridge M, Lapinsky S, Muscedere J, Barton J, Griesdale D, Soth M, Ambosta A, Lebovic G, Wald R; Canadian Critical Care Trials Group.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):496-505. doi: 10.2215/CJN.05530518. Epub 2019 Mar 21.

PMID:
30898872
16.

Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis.

Nazzani S, Bandini M, Preisser F, Mazzone E, Marchioni M, Tian Z, Stubinski R, Clementi MC, Saad F, Shariat SF, Montanari E, Briganti A, Carmignani L, Karakiewicz PI.

Surg Oncol. 2019 Mar;28:201-207. doi: 10.1016/j.suronc.2019.01.011. Epub 2019 Jan 29.

PMID:
30851901
17.

Shift Work Patterns, Chronotype, and Epithelial Ovarian Cancer Risk.

Leung L, Grundy A, Siemiatycki J, Arseneau J, Gilbert L, Gotlieb WH, Provencher DM, Aronson KJ, Koushik A.

Cancer Epidemiol Biomarkers Prev. 2019 Mar 6. doi: 10.1158/1055-9965.EPI-18-1112. [Epub ahead of print]

PMID:
30842128
18.

Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer.

Gulley JL, Borre M, Vogelzang NJ, Ng S, Agarwal N, Parker CC, Pook DW, Rathenborg P, Flaig TW, Carles J, Saad F, Shore ND, Chen L, Heery CR, Gerritsen WR, Priou F, Langkilde NC, Novikov A, Kantoff PW.

J Clin Oncol. 2019 Feb 28:JCO1802031. doi: 10.1200/JCO.18.02031. [Epub ahead of print]

PMID:
30817251
19.

Translating the role of PARP inhibitors in triple-negative breast cancer.

Beniey M, Haque T, Hassan S.

Oncoscience. 2019 Jan 31;6(1-2):287-288. doi: 10.18632/oncoscience.474. eCollection 2019 Jan. No abstract available.

20.

Distinct Histologic, Immunohistochemical and Clinical Features Associated With Serous Endometrial Intraepithelial Carcinoma Involving Polyps.

Trinh VQ, Pelletier MP, Echelard P, Warkus T, Sauthier P, Gougeon F, Mès-Masson AM, Provencher DM, Rahimi K.

Int J Gynecol Pathol. 2019 Feb 14. doi: 10.1097/PGP.0000000000000591. [Epub ahead of print]

PMID:
30789501

Supplemental Content

Loading ...
Support Center